1 | FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. International Journal of Cancer, 2015, 136(5): E359-E386. | 2 | CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015[J]. A Cancer Journal for Clinicians, 2016, 66(2): 115-132. | 3 | 高庆蕾, 孔北华, 尹如铁, 等. PARP抑制剂治疗复发性卵巢癌专家共识[J]. 现代妇产科进展, 2018, 27(10): 721-725. | 3 | GAO Q L, KONG B H, YIN R T, et al. Expert consensus on PARP inhibitors in the treatment of recurrent ovarian cancer[J]. Progress in Obstetrics and Gynecology, 2018, 27(10): 721-725. | 4 | MORGAN R J, ARMSTRONG D K, ALVAREZ R D, et al. Ovarian cancer, Version 1.2016, NCCN clinical practice guidelines in oncology[J]. Journal of the National Comprehensive Cancer Network, 2016, 14(9): 1134-1163. | 5 | 张可辉, 张亮仁, 张礼和, 等. PARP-1抑制剂在抗肿瘤方面的研究进展[J]. 中国药学杂志, 2010, 45(22): 1689-1694. | 5 | ZHANG K H, ZHANG L R, ZHANG L H, et al. Research progress of PARP-1 inhibitors in anti-tumor[J]. Chinese Pharmaceutical Journal, 2010, 45(22): 1689-1694. | 6 | Center for Drug Evaluation and Research. Application number: 208447Orig1s000 chemistry review (s)[EB]. [2016-02-18]. . | 7 | Center for Drug Evaluation and Research. Application number: 209115Orig1s000 chemistry review (s)[EB]. [2016-02-18]. . | 8 | Center for Drug Evaluation and Research. Application number: 208558Orig1s000 chemistry review (s)[EB]. [2016-02-18]. . | 9 | Center for Drug Evaluation and Research. Application number: 211651Orig1s000 chemistry review (s)[EB]. [2017-02-14]. . | 10 | 郑云龙, 王进美, 孙正琪, 等. 壳聚糖/明胶抗菌微胶囊的制备及其应用[J]. 化工进展, 2020, 39(3): 1137-1144. | 10 | ZHENG Y L, WANG J M, SUN Z Q, et al. Preparation and application of chitosan/gelatin antibacterial microcapsule[J]. Chemical Industry and Engineering Progress, 2020, 39(3): 1137-1144. | 11 | 陈龙, 周红军, 江海科, 等. 叶面亲和型阿维菌素微胶囊的制备及pH响应性释放性能[J]. 化工进展, 2020, 39(1): 348-355. | 11 | CHEN L, ZHOU H J, JIANG H K, et al. Preparation and pH responsive release properties of foliar affinity avermectin microcapsules[J]. Chemical Industry and Engineering Progress, 2020, 39(1): 348-355. | 12 | 李静涵, 魏振平. 亲水性小分子药物缓释微球制备方法的研究进展[J]. 化工进展, 2016, 35(1): 204-209. | 12 | LI J H, WEI Z P. Recent development on the microencapsulation of hydrophilic small molecular drugs[J]. Chemical Industry and Engineering Progress, 2016, 35(1): 204-209. | 13 | 辛露露, 李付军, 薛飞, 等. 大蒜素/海藻酸钠/明胶/壳聚糖复合微球的制备及性能[J]. 化工进展, 2017, 36(10): 3826-3831. | 13 | XIN L L, LI F J, XUE F, et al. Preparation and properties of allicin/sodium alginate/gelatin/chitosan composite microspheres[J]. Chemical Industry and Engineering Progress, 2017, 36(10): 3826-3831. | 14 | 古一雯. 微粉硅胶在制剂工艺中的应用[J]. 安徽医药, 2008, 12(10): 981-982. | 14 | GU Y W. Application of silica gel powder in preparation technology[J]. Anhui Medical and Pharmaceutical Journal, 2008, 12(10): 981-982. | 15 | SADEK H M, OLSEN J L, SMITH H L, et al. A systematic approach to glidant selection[J]. Pharmaceutical Development and Technology, 1982, 6(2): 43-62. | 16 | 解立斌, 霍军生, 黄建. 食品粉粒体混合: 混合机理与混合均匀度影响因素探讨[J]. 中国食品添加剂, 2011(4): 32-36. | 16 | XIE L B, HUO J S, HUANG J. Food powder mixing: the research on mixing mechanism and factors influence mixing homogeneity[J]. China Food Additives, 2011(4): 32-36. | 17 | WITHEY R J, MAINVILLE C A. A critical analysis of a capsule dissolution test[J]. Journal of Pharmaceutical Sciences, 1969, 58(9): 1120-1126. |
|